Bizarre Patents
A kissing shield comprised of a thin, flexible membrane and a frame or holder.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6600494 | Color reduction for a remote control system A method and a system for a fast and reliable color reduction from multiple bit color representations to 4 bit color representations. The method for color reduction in a computer system having a three color model for color representation of a pixel, each ... | 07/29/2003 |
| 6570584 | Broad color gamut display A digital color image display device, includes a plurality of pixels, each pixel having a plurality of subpixels with at least one of the subpixels producing a color other than red, green or blue.... | 05/27/2003 |
| 6429868 | Method and computer program for displaying quantitative data A method and computer program for simultaneously displaying very large sets of quantitative data. The method and computer program permit the display of quantitative data without first standardizing the data. The method and computer program also permit an ... | 08/06/2002 |
| 6373491 | Image processing device, image processing method and program distribution medium and data distribution medium for processing images An image processing device and method for processing an image defined by a combination of unit graphic forms or polygons are provided with an interpolated line completion unit which determines an interpolated line which is the line that interpolates a spa... | 04/16/2002 |
| 6356273 | Method and system for performing MIP map level selection A method and system for processing textures for a graphical image on a display is disclosed. The graphical image includes a plurality of polygons. Each of the plurality of polygons includes at least one fragment. The fragment includes at least one texture... | 03/12/2002 |
| 6335739 | Terminal operation system In electronic conference systems, a terminal operation system prevents a conflict of operations to a plurality of processing objects displayed on a shared screen of an operated terminal, enhances smooth proceeding of the conference and realizes easier ope... | 01/01/2002 |
| 5468481 | MHC class II-peptide conjugates useful in ameliorating autoimmunity The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease.... | 11/21/1995 |
| 5437864 | Method of inhibiting blood coagulation in extracorporeal circulation by inhibiting human tissue factor This invention provides a method of inhibiting coagulation in extracorporeal circulation in a subject, comprising administration of a therapeutically effective amount of a monoclonal antibody which inhibits the ability of tissue factor to bind to factor V... | 08/01/1995 |
| 5366728 | Stable forms of antigenic Taenia ovis polypeptides Stable forms of Taenia ovis peptide antigens, such as portions of a T. ovis oncosphere antigen which runs as a 47-52 kDa doublet, are suitable for use in vaccines to protect ruminants against infection by cestode parasites. The antigens are preferably obt... | 11/22/1994 |
| 5330753 | Cholera vaccines The gene encoding the TcpA pilus has been cloned. It encodes a protein useful in live, killed-cell, and synthetic vaccines. Protein production is enhanced by specific medium conditions.... | 07/19/1994 |
| 5324822 | Method of isolating a CA 195-like immunoreactive antigen from human amniotic fluid A method of isolation of a material with similar immunological properties to CA-195 from human amniotic fluid has been disclosed. This material can be substituted for CA-195 in many processes, for example in the preparation of analytical control materials... | 06/28/1994 |
| 5310892 | Nucleic acid sequence which codes for and expresses human fibrillarin and uses thereof Substantially pure nucleic acid sequences coding for human fibrillarin have been identified and isolated. The isolated material is used to generate the protein in vitro, which is then used to identify autoimmune antibodies in patients suffering from scler... | 05/10/1994 |
| 5308614 | Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones The present invention relates to an improved method for the production of antibodies to tumor-associated gangliosides using ganglioside lactones. The resulting antibodies are useful in the detection and treatment of tumors containing gangliosides. The pre... | 05/03/1994 |
| 5298605 | Antibodies to islet amyloid polypeptide (IAPP) and subunits thereof This invention is directed to antibodies which react with human islet amyloid polypeptide and which do not significantly react with insulin or calcitonin gene-related peptides. Preparations of antibodies are provided which bind to islet amyloid polypeptid... | 03/29/1994 |
| 5284935 | MHC-mediated toxic conjugates useful in ameliorating autoimmunity The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X--MHC--peptide or MHc--peptide--X wherein X represents a functional moiety selected from a toxin and a labeling group; MH... | 02/08/1994 |
| 5268454 | Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier Conjugates of stable nonimmunogenic polymers and analogs of immunogens that possess the specific B cell binding ability of the immunogen but lack T cell epitopes and which, when introduced into individuals, induce humoral anergy to the immunogen are discl... | 12/07/1993 |
| 5260422 | MHC conjugates useful in ameliorating autoimmunity The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease.... | 11/09/1993 |
| 5256768 | Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics Bacterially synthesized polypeptides that are recognized by antibodies produced in EBV-infected humans are disclosed. Plasmids containing DNA sequences encoding portions of the EBNA and EBEA-D antigens are also disclosed, as are methods for expressing the... | 10/26/1993 |
| 5250661 | Established cell line B cell differentiation factor which acts on B cells and participates in their differentiation into antibody-producing cells is produced by an established cell line.... | 10/05/1993 |
| 5247208 | Substrate bias generating device and operating method thereof A substrate bias generating circuit including waveform shaping circuits for producing two signals having different phases on the basis of signals in phase extracted from a ring oscillator and two logic gates using these two signals having large phase diff... | 09/21/1993 |
| 5242687 | Method of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cells Specific and nonspecific immunomodulation, enhancement of cellular engraftment, and modulation of nonimmune cells are achieved by using various membrane-binding and soluble CD8 compositions.... | 09/07/1993 |
| 5235049 | Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1 The present invention relates to a soluble form of intercellular adhesion molecule (sICAM-1) and purified and isolated human sICAM-1. This invention also relates to a purified and isolated DNA sequence encoding sICAM-1. The extracellular domain of sICAM-1... | 08/10/1993 |
| 5231000 | Antibodies to A4 amyloid peptide Monoclonal antibodies to a 28-mer peptide present within A4-amyloid are described. These antibodies exhibit unexpected specificity for amyloid plaque structures previously unrecognized in Alzheimer's disease brains. These monoclonal antibodies are useful ... | 07/27/1993 |
| 5229667 | Delay unit implemented by inverting circuits associated with capacitive load for increasing delay A delay unit incorporated in a standard cell type semicustom-made integrated circuit comprises a plurality of complementary inverting circuits coupled in cascade for introducing a time delay into propagation of a signal, and a lead circuit coupled to one ... | 07/20/1993 |
| 5229289 | Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates A method of producing monoclonal antibodies that bind to human cancer-associated mucin-type glycoprotein antigens comprising: (1) immunizing a host with a core structure of a mucin-type glycoprotein: (2) fusing splenocytes from said immunized host with my... | 07/20/1993 |
| 5223427 | Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain Murine hybridomas producing monoclonal antibodies capable of immunoreacting with huTFh and polypeptide analogs are described. Also contemplated are immunologic methods for detecting huTF heavy chain in body fluid, detecting thrombic events in vivo, isolat... | 06/29/1993 |
| 5223254 | Respiratory syncytial virus: vaccines Polypeptides, nucleotides, and compositions useful for preparing diagnostic reagents for and vaccines against human Respiratory Syncytial Virus are disclosed. The polypeptides include short polypeptides which are related to a neutralizing and fusion epito... | 06/29/1993 |
| 5223417 | Method for transforming human B lymphocytes Disclosed herein is a method for transforming human B-cells preferably by infecting them with Epstein-Barr virus followed by transforming the Epstein Barr virus infected cells with an activated human ras gene. The transformed cells are useful for producin... | 06/29/1993 |
| 5214317 | CMOS to ECL translator with incorporated latch An electrical circuit is disclosed which implements a CMOS to ECL translator with an incorporated latch. The invention provides a circuit which uses a small number of devices, and provides fast transition times with low power consumption.... | 05/25/1993 |
| 5209929 | Immunization against Babesiosis using purified merozoite surface antigens of Basesia bigemina Antigenic surface proteins from the intraerythrocytic merozoite stage of Babesia bigemina have been isolated using cell fusions and monoclonal antibodies produced thereby. Immunization of mammals, such as bovines, with purified isolates induces an immunol... | 05/11/1993 |
| 5202116 | Methods for controlling human endothelial cell proliferation and effector functions using oncostatin M The present invention is directed to the use of a recently discovered cytokine, Oncostatin M, to control endothelial cell immunogenicity, fibrinolytic activity and proliferation, and to its use in the treatment of a variety of human vascular and immune sy... | 04/13/1993 |
| 5196352 | New FK-506 cytosolic binding protein A new homogeneous cytosolic binding (HCB) protein, having a specific binding activity of about 26 μg FK-506 per mg protein and a molecular weight of about 10-12 kilodaltons, reversibly binds the immunosuppressant FK-506 but not cyclosporine A (CSA). The ... | 03/23/1993 |
| 5194425 | MHC-mediated toxic conjugates useful in ameliorating autoimmunity The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X1 MHC2 peptide or MHC2 peptide1 X wherein X represents a functional moiety se... | 03/16/1993 |
| 5192538 | Stable forms of antigenic Taenia ovis polypeptides This invention relates to stable forms of peptide antigens of T. ovis suitable for use in vaccines to protect ruminants against infection by cestode parasites. The antigens are preferably obtained by expression of DNA coding therefor in a recombinant host... | 03/09/1993 |
| 5191233 | Flip-flop type level-shift circuit In a flip-flop type level-shift circuit, a P-channel MOS transistor whose gate and drain are tied together is connected between a higher potential power supply terminal and a gate of an output stage P-channel MOS transistor. The P-channel MOS transistor t... | 03/02/1993 |
| 5182520 | Non-linear de-emphasis circuit In an apparatus for non-linear de-emphasis of an input signal, an amplitude limiting signal is obtained by subtracting a high-pass filtered and amplitude limited input signal from the original input signal, then the amplitude limiting signal is amplified ... | 01/26/1993 |
| 5180814 | Tumor specific monoclonal antibodies A human monoclonal antibody having specificity for an epitope in a tumor associated antigen, said antibody produced by a cell line selected from the group consisting of Co6a3-1 (HB8493), Co7a4 (HB8494), Co28A32 (HB9380), Co16-86 (HB8496), and Co16-88 (HB8... | 01/19/1993 |
| 5132222 | Established cell line, KML1-7, which produces B-cell differentiation factor (BCDF) A novel established cell line, KML1-7, obtained by collecting lymphoid cells from an animal with autoimmune disease, culturing them in a culture medium containing the supernatant of a culture in which lymphoid cells of animal origin have been g... | 07/21/1992 |
| 5130416 | Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from plasmodium falciparum A histidine rich antigen, designated PfHRP-II, has been synthesized from a recombinant DNA clone containing a genomic fragment of Plasmodium falciparum. PfHRP-II is a protein exported from the parasite into the body fluid. This protein passes through the ... | 07/14/1992 |
| 5130297 | Conjugates useful in ameliorating autoimmunity MHC-II-peptide The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X--MHC--peptide or MHC--peptide--X wherein X represents a functional moiety selected from a toxin and a labeling group; MH... | 07/14/1992 |
